CA
AMED

Continuum Advisory’s Amedisys AMED Stock Holding History

Continuum Advisory’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12
Closed -$1.1K – 1918
2024
Q2 		$1.1K Hold
12
– – ﹤0.01% 1449
2024
Q1 		$1.14K Buy
+12
New +$1.13K ﹤0.01% 1444

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Continuum Advisory's AMED Position: Q3 2024 in Review

Continuum Advisory sold out of Amedisys (AMED) in Q3 2024, closing a stake of 12 shares — an estimated $1.1K sold.

Continuum Advisory first reported a position in AMED in Q1 2024 and held it in 2 quarters. The position peaked at $1.14K in Q1 2024. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Continuum Advisory reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Continuum Advisory sold 12 Amedisys shares in Q3 2024, an estimated $1.1K.
  • Continuum Advisory first reported a position in Amedisys in Q1 2024 and held it in 2 quarters.
  • Continuum Advisory's Amedisys position peaked at $1.14K in Q1 2024.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Continuum Advisory's 13F filing for Q3 2024, filed 15 Nov 2024.